Enanta Pharmaceuticals
ENTA
#8068
Rank
C$0.53 B
Marketcap
C$18.46
Share price
0.93%
Change (1 day)
28.15%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -C$70.13 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$65.25 Million. In 2025 the company made an earning of -C$91.11 Million, an increase over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$70.13 Million-23.03%
2025 -C$91.11 Million-34.07%
2024 -C$0.14 Billion-23.87%
2023 -C$0.19 Billion4.39%
2022 -C$0.18 Billion-4.4%
2021 -C$0.19 Billion91.12%
2020 -C$95.17 Million-407.13%
2019 C$30.98 M-78.63%
2018 C$0.14 B117.97%
2017 C$66.53 M-574.65%
2016 -C$14.02 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$25.18 Million-137.98%
2012 C$66.27 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.33 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.11 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$12.39 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.18 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.95 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.96 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA